These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1008 related items for PubMed ID: 19429299

  • 1. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M, Hebert S, Suntres ZE, Lafrenie RM, Azghani AO, Omri A.
    Int J Pharm; 2009 May 21; 373(1-2):141-6. PubMed ID: 19429299
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes.
    Alipour M, Suntres ZE, Lafrenie RM, Omri A.
    J Antimicrob Chemother; 2010 Apr 21; 65(4):684-93. PubMed ID: 20159770
    [Abstract] [Full Text] [Related]

  • 3. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin.
    Halwani M, Blomme S, Suntres ZE, Alipour M, Azghani AO, Kumar A, Omri A.
    Int J Pharm; 2008 Jun 24; 358(1-2):278-84. PubMed ID: 18448284
    [Abstract] [Full Text] [Related]

  • 4. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M, Yebio B, Suntres ZE, Alipour M, Azghani AO, Omri A.
    J Antimicrob Chemother; 2008 Dec 24; 62(6):1291-7. PubMed ID: 18931388
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.
    Alhariri M, Omri A.
    Antimicrob Agents Chemother; 2013 Jan 24; 57(1):569-78. PubMed ID: 23147741
    [Abstract] [Full Text] [Related]

  • 6. The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosa.
    Mahdiun F, Mansouri S, Khazaeli P, Mirzaei R.
    Microb Pathog; 2017 Jun 24; 107():129-135. PubMed ID: 28323149
    [Abstract] [Full Text] [Related]

  • 7. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa.
    Alipour M, Dorval C, Suntres ZE, Omri A.
    J Pharm Pharmacol; 2011 Aug 24; 63(8):999-1007. PubMed ID: 21718282
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M, Traore H, El Manssouri N, Vanderbist F, Vaneechoutte M, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2009 Oct 24; 34(4):370-4. PubMed ID: 19505804
    [Abstract] [Full Text] [Related]

  • 9. Analysis of quorum sensing-dependent virulence factor production and its relationship with antimicrobial susceptibility in Pseudomonas aeruginosa respiratory isolates.
    Karatuna O, Yagci A.
    Clin Microbiol Infect; 2010 Dec 24; 16(12):1770-5. PubMed ID: 20132256
    [Abstract] [Full Text] [Related]

  • 10. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct 24; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2008 Apr 24; 31(4):329-36. PubMed ID: 18280117
    [Abstract] [Full Text] [Related]

  • 12. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
    Tré-Hardy M, Macé C, El Manssouri N, Vanderbist F, Traore H, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2009 Jan 24; 33(1):40-5. PubMed ID: 18801647
    [Abstract] [Full Text] [Related]

  • 13. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A, Lajoie B, El Hage S, Baziard G, Roques C.
    Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1676-86. PubMed ID: 26711774
    [Abstract] [Full Text] [Related]

  • 14. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa.
    Alipour M, Suntres ZE, Omri A.
    J Antimicrob Chemother; 2009 Aug 28; 64(2):317-25. PubMed ID: 19465435
    [Abstract] [Full Text] [Related]

  • 15. Growth inhibition of adherent Pseudomonas aeruginosa by an N-butanoyl-L-homoserine lactone analog.
    Khalilzadeh P, Lajoie B, El Hage S, Furiga A, Baziard G, Berge M, Roques C.
    Can J Microbiol; 2010 Apr 28; 56(4):317-25. PubMed ID: 20453898
    [Abstract] [Full Text] [Related]

  • 16. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P, Neville M, Malinin V, Scotto AW, Sardaryan G, Kurumunda R, Mackinson C, James G, Fisher S, Perkins WR.
    J Antimicrob Chemother; 2008 Apr 28; 61(4):859-68. PubMed ID: 18305202
    [Abstract] [Full Text] [Related]

  • 17. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y, Yu XH, Wang R, An MM, Liang BB.
    J Pharm Pharmacol; 2009 Sep 28; 61(9):1257-62. PubMed ID: 19703377
    [Abstract] [Full Text] [Related]

  • 18. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance.
    Landry RM, An D, Hupp JT, Singh PK, Parsek MR.
    Mol Microbiol; 2006 Jan 28; 59(1):142-51. PubMed ID: 16359324
    [Abstract] [Full Text] [Related]

  • 19. Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosa.
    Busetti A, Shaw G, Megaw J, Gorman SP, Maggs CA, Gilmore BF.
    Mar Drugs; 2014 Dec 24; 13(1):1-28. PubMed ID: 25546516
    [Abstract] [Full Text] [Related]

  • 20. Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa.
    Lagacé J, Dubreuil M, Montplaisir S.
    J Microencapsul; 1991 Dec 24; 8(1):53-61. PubMed ID: 1908898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.